Philip Helliwell

Philip Helliwell is Professor of Clinical Rheumatology at the University of Leeds and Honorary Consultant Rheumatologist for the Leeds Teaching Hospitals and the Bradford Teaching Hospitals NHS Trust. Dr Helliwell established and led the CASPAR study for classification of psoriatic arthritis, worked with the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in developing single and composite outcome measures in psoriatic arthritis, and completed the first treat-to...See more

Philip Helliwell is Professor of Clinical Rheumatology at the University of Leeds and Honorary Consultant Rheumatologist for the Leeds Teaching Hospitals and the Bradford Teaching Hospitals NHS Trust. Dr Helliwell established and led the CASPAR study for classification of psoriatic arthritis, worked with the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in developing single and composite outcome measures in psoriatic arthritis, and completed the first treat-to-target strategy study (TICOPA) in early psoriatic arthritis. He is a member of the ASAS, Co-Founder and Past-President of GRAPPA, Co-Founder of the Bradford (University) Diploma in Rheumatology and Musculoskeletal Medicine, a former member of the Bradford and Airedale Musculoskeletal Alliance, and Co-Founder of the Leeds foot and ankle studies group. Dr Helliwell has contributed to several national and international guidelines on the management of psoriatic arthritis and foot and ankle problems and has published over 400 peer-reviewed papers. See less